Clinical Trial Update: Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated AG-013736 in combination with standard-of-care therapies in patients with advanced solid tumors. The study has completed and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• AG-013736

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2012-03-27